4 February 2025 - The MHRA has today approved the vaccine chikungunya vaccine (live) (Ixchiq) to protect adults against chikungunya disease, caused by the chikungunya virus.
The vaccine has been approved by the MHRA under the International Recognition Procedure, after confirming it meets the UK regulator’s standards of safety, quality, and effectiveness.